Elsevier

Respiratory Medicine

Volume 99, Issue 12, December 2005, Pages 1485-1493
Respiratory Medicine

Safety of formoterol after cumulative dosing via Easyhaler® and Aerolizer®

https://doi.org/10.1016/j.rmed.2005.08.023Get rights and content
Under an Elsevier user license
open archive

Summary

This randomised, double-blind, double-dummy, cumulative dose, multicentre crossover study aimed to demonstrate non-inferiority in safety of formoterol delivered via Easyhaler® versus Aerolizer®. The secondary objective was to compare the efficacy of the devices.

Thirty-three adult asthmatic subjects entered the study and 32 completed it. The study comprised screening and two study days, with each subject inhaling 96 μg (12, 12, 24 and 48 μg) cumulative dose of formoterol via the study inhalers. Serum potassium (S-K+), vital signs and spirometry were performed at baseline, 1 h after each dose and additionally 4 h after the last dose.

The primary safety variable was S-K+. Secondary safety variables were heart rate, corrected QT interval, blood pressure, serum glucose and adverse events. Spirometry was assessed to evaluate efficacy.

The results showed non-inferiority in safety of formoterol inhaled via Easyhaler® compared to Aerolizer®. The adjusted treatment difference in the S-K+ values after 96 μg cumulative dose of formoterol was 0.14 mmol/L being clearly above the pre-determined lower limit of the non-inferiority criterion of −0.2 mmol/L. There were dose-related changes in secondary efficacy variables after both treatments. The changes were comparable in most of the parameters but heart rate was statistically significantly higher and decrease in diastolic blood pressure greater after formoterol via Aerolizer® than that via Easyhaler®. The occurrence of adverse events was dose-related, the most common events being tremor, hypokalaemia, headache and palpitation. The spirometry results showed no statistically significant difference in efficacy between the treatments.

In conclusion, formoterol delivered via Easyhaler® was as safe as via Aerolizer®.

Keywords

Asthma
Formoterol
Easyhaler®
Aerolizer®
Dry powder inhaler

Cited by (0)